Robert C. Strauss

Robert C. Strauss

Direttore/Membro del Consiglio presso Percardia, Inc.

82 anni
Health Technology
Consumer Services
Electronic Technology

Profilo

Robert C.
Strauss
is a Director of Percardia, Inc. He has been Chairman, President, and Chief Executive Officer of Noven Pharmaceuticals, Inc. since June 2001.
Most recently, he was Chairman, President, and Chief Executive Officer of Cordis Corp.
from 1983 to 1997.
Mr. Strauss was President, Chief Operating Officer, and a Director of IVAX Corp.
from March 1997 to July 1997.
He was a Director of CardioGenesis Corp., Columbia Laboratories, Inc., and Salient Surgical Technologies, Inc. Previously, he was President, Chief Executive Officer, and a Director of Noven Pharmaceuticals from December 1997 to September 2000 and Co-Chairman from September 2000 to June 2001.
Mr. Strauss received a Bachelor of Science degree in Engineering Physics from University of Illinois and a Master of Science degree in Physics from the University of Idaho.

Posizioni attive di Robert C. Strauss

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Tutte le posizioni attive di Robert C. Strauss

Precedenti posizioni note di Robert C. Strauss

SocietàPosizioneFine
Amministratore Delegato 03/01/2008
JUNIPER PHARMACEUTICALS INC Direttore/Membro del Consiglio 31/12/2005
Direttore/Membro del Consiglio 01/07/2005
Presidente -
Presidente -
Vedi nel dettaglio l'esperienza di Robert C. Strauss

Formazione di Robert C. Strauss

University of Illinois Undergraduate Degree
University of Idaho Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Robert C. Strauss

Relazioni

23

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private7

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Robert C. Strauss
-40% Proroga eccezionale: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA